Development asset linked to Anixa Biosciences in public FDA and regional records.
pharma · Ovarian Cancer · Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer · ANIX
Anixa Biosciences
Anixa Biosciences Inc
Anixa Biosciences drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
San Jose, USA HQ
1982 Founded
12 Employees
Public company Type
ANIX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Jose, USA
- Founded
- 1982
- Employees
- 12
- Programs
- 2
- Drugs
- 4
- Patents
- 1
Anixa Biosciences pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Anixa Biosciences drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Anixa Biosciences in public FDA and regional records.
-
Development asset linked to Anixa Biosciences in public FDA and regional records.
-
Development asset linked to Anixa Biosciences in public FDA and regional records.